Denali TherapeuticsDNLI

那斯達克 · USD
19.45
+0.59
(+3.13%)
收盤 11/04 04:59 (UTC+8)
盤後 
20.48 
+1.03 
(+5.30%)
11/04 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • 0.04
  • 0.18
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • 393.29
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q3
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
營業收入淨額
17,778
3,604
-
-
-
-
-
-
-
-
營業成本
-93--------
營業毛利
-
3,511
-
-
-
-
-
-
-
-
營業費用
-134,052137,357137,365137,434134,963----
研發費用
-97,019103,84697,905101,950102,696116,22799,78798,23891,399
推銷及管理費用
-36,28333,51139,46035,48432,26729,35330,05924,94925,194
非經常性項目費用
----------
其他營業費用
-750--------
營業利益
-126,751
-130,541
-137,357
-137,365
-137,434
-134,963
-145,580
-129,846
-123,187
-116,593
其他收入及費用
-2,9888,9108,91810,53210,84412,61015,16115,99517,567
利息費用
----------
稅前純益
-
-127,553
-128,447
-128,447
-126,902
-124,119
-132,970
-114,685
-107,192
-99,026
所得稅
---102---68--
稅後純益
70,126
-127,553
-128,447
-128,549
-126,902
-124,119
-132,970
-114,753
-107,192
-99,026
基本每股稅後盈餘(元)
0.37-0.68-0.69-0.73-0.74-0.72-0.78-0.67-0.63-0.59
稀釋每股稅後盈餘(元)
0.37-0.68-0.69-0.73-0.74-0.72-0.78-0.68-0.63-0.58
基本平均股數(千股)
188387.00187314.00186636.00175458.00172421.00171449.00171222.00170086.00169456.00168831.00
稀釋平均股數(千股)
192077.00187314.00186636.00175458.00172421.00171449.00171222.00170086.00169456.00168831.00
還原基本每股稅後盈餘(元)
0.37-0.68-0.69-0.73-0.74-0.72-0.78-0.67-0.63-0.59
還原稀釋每股稅後盈餘(元)
0.37-0.68-0.69-0.73-0.74-0.72-0.78-0.68-0.63-0.58
還原基本平均股數(千股)
188,387187,314186,636175,458172,421171,449171,222170,086169,456168,831
還原稀釋平均股數(千股)
192,077187,314186,636175,458172,421171,449171,222170,086169,456168,831
EBITDA(千元)
70,126-124,514-125,945-126,307-125,066-122,860-133,646-118,231-113,301-107,142

大家都在看

HOT